Gabapentin for Alcohol Relapse Prevention

Completed · Phase 2 · Has a placebo group

Conditions studied: Alcohol Use Disorder, Alcohol Withdrawal

In brief

This treatment study is a 16-weeks outpatient clinical trial where subjects with alcohol dependence will get medication, which might help them to reduce or stop their drinking, or a placebo ( placebo is a capsule that looks the same as the investigational drug, but has no real medication. It is a "sugar pill").

Key facts

Study ID

NCT02349477

Run by

Medical University of South Carolina

People needed

96

Starts

2014-11-01

Expected to finish

2018-08-27

Last updated by the study team

2019-11-04

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets criteria for alcohol use disorder based on DSM-5 criteria
• Meets criteria for history of alcohol withdrawal based on DSM-5 criteria
• Able to maintain abstinence for a minimum of 3 days prior to randomization as verified by self report, urine ETG, and breathalyzer.

You may not qualify if…

• Significant psychiatric or medical illness
• No other substance abuse
• Taking other medications known to treat alcohol use disorder
• Unstable living arrangements
• Significant legal problems pending

Where it is running

• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.